In the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, IL-6 is thought to be involved in the cytokine storm following infection and treatment of patients with IL-6 inhibitors is currently under review [46]. This evidence concerns the gene IL6 and COVID-19.